current research
The Wang Lab is a multidisciplinary research group focusing on molecular engineering, photomedicine, targeted drug delivery and genome editing.
 
Currently, the key research areas in the group are (i) engineering stimuli-responsive nanomaterials for drug delivery; (ii) ocular drug delivery;  (iii) engineering genetic systems (CRISPR/Cas9) in stem cells or for disease treatment; and (iv) regulating autophagy for cancer therapy or Alzheimer’s treatment.